Our previous research has demonstrated that impaired mCa2+ efflux contributes to mCa2+ overload, accelerating the progression of Alzheimer’s disease (AD) and leading to cognitive decline in 3xTg-AD mouse models expressing amyloid beta (Aβ) and tau proteins. Here, MAPT is linked to Alzheimer disease.